Ousseny Zerbo, PhD

ousseny.x.zerbo@kp.org

Kaiser Permanente Researcher Profiles

Zerbo, Ousseny

Ousseny Zerbo, PhD, is a Research Scientist in the Vaccine Study Center at Kaiser Permanente Northern California Division of Research. His research interest is in maternal vaccination during pregnancy and early childhood health outcomes, vaccine uptake, safety and effectiveness. He is the principal investigator on two NIH-funded projects to investigate the effectiveness of influenza vaccination, COVID-19 vaccination during pregnancy, and infant risk of influenza and COVID-19. He also studies risk factors associated with autism spectrum disorders.

Prior to joining the Vaccine Study Center, he completed post-doctoral training in the Autism Research Program at the Division of Research. He received his PhD in epidemiology from the University of California Davis and his bachelor’s degree in biological science and teaching credential from the University of Ouagadougou, Burkina Faso, West Africa.

Current Positions

  • Research Scientist II

Section Affiliations

Primary Research Interests

  • Vaccine safety and effectiveness
  • Autism spectrum disorder

Related Websites

Studies

A Post-Marketing Safety Study to Evaluate the Safety of Respiratory Syncytial Virus Vaccine (ABRYSVO) Exposure During Pregnancy in an Integrated Healthcare System in the United States

This study will estimate the risk of preterm birth and hypertensive disorders of pregnancy following exposure to Respiratory Syncytial Virus Vaccine (ABRYSVO) during pregnancy.

Investigator: Zerbo, Ousseny

Funder: Pfizer Inc.

COVID-19 Vaccine Effectiveness in Pregnant Women and their Infants

The overall goals are to: Determine COVID-19 vaccine effectiveness in pregnant women for preventing laboratory-confirmed COVID-19 and hospitalization for COVID-19 using real-world clinical data; Determine effectiveness of maternal COVID-19 vaccination during pregnancy for infants 0-12 months for outcomes of laboratory-confirmed COVID-19, and hospitalization for COVID-19, and determine whether effectiveness varies by trimester of vaccination; Estimate COVID-19 vaccination rates among pregnant women and identify sociodemographic, geographic clusters and other factors associated with being unvaccinated.

Investigator: Zerbo, Ousseny

Funder: National Institute of Allergy and Infectious Diseases

Analysis to evaluate the effectiveness of a serogroup B outer membrane vesicle meningococcal vaccine against gonorrhea

The goal of this study is to use electronic medical records from 2016 to 2020 to evaluate the protective effect of MenB-4C vaccine against gonococcal infections among 16- to 23-year-old persons.

Investigator: Zerbo, Ousseny

Funder: Centers for Disease Control and Prevention

Effect of Maternal Influenza Vaccination during Pregnancy on Risk of Infant Influenza

This project has three major aims: 1) to examine whether influenza vaccination during pregnancy prevents influenza and other respiratory infections in infants aged 0 to 12 months, with a sub-aim to examine the effect of vaccine timing during pregnancy on these outcomes; 2) to evaluate the effect of maternal influenza vaccination during pregnancy on the effectiveness of influenza vaccine administered to infants; and 3) to examine whether influenza non-vaccination during pregnancy clusters geographically, and determine if those clusters are associated with influenza and influenza-like illnesses during pregnancy.

Investigator: Zerbo, Ousseny

Funder: National Institute of Allergy and Infectious Diseases

Publications

Effectiveness of a serogroup B meningococcal vaccine against gonorrhea: A retrospective study

Authors: Abara, Winston E;Modaressi, Sharareh;Fireman, Bruce;Klein, Nicola P;Layefsky, Evan;Goddard, Kristin;Bernstein, Kyle T;Kirkcaldy, Robert D;Zerbo, Ousseny

Vaccine. 2024 Sep 10;42(26):126312. Epub 2024-09-10.

PubMed abstract

Safety of the Seasonal Influenza Vaccine in 2 Successive Pregnancies

Authors: Getahun, Darios;Zerbo, Ousseny;Qian, Lei;et al.

JAMA Netw Open. 2024 Sep 03;7(9):e2434857. Epub 2024-09-03.

PubMed abstract

Effectiveness of the Original Monovalent and Bivalent COVID-19 Vaccines Against COVID-19-Associated Emergency Department and Urgent Care Encounters in Pregnant Persons Who Were Not Immunocompromised: VISION Network, June 2022-August 2023

Authors: Avrich Ciesla, Allison;Klein, Nicola P;Zerbo, Ousseny;Zerbo, Ousseny;et al.

Open Forum Infect Dis. 2024 Sep;11(9):ofae481. Epub 2024-08-28.

PubMed abstract

Trends in Gonorrhea and Chlamydia Testing and Infections Across the COVID-19 Pandemic in Adolescents and Young Adults in an Integrated Health System

Authors: Pelliccione, Alex;Modaressi, Sharareh;Fireman, Bruce;Layefsky, Evan;Klein, Nicola P;Luu, Mitchell N;Zerbo, Ousseny

J Adolesc Health. 2024 Aug 15.

PubMed abstract

COVID-19 Vaccination in the First Trimester and Major Structural Birth Defects Among Live Births

Authors: Kharbanda, Elyse O;Zerbo, Ousseny;Vazquez-Benitez, Gabriela;et al.

JAMA Pediatr. 2024 Aug 01;178(8):823-829.

PubMed abstract

Influenza Vaccine Effectiveness Against Influenza A-Associated Emergency Department, Urgent Care, and Hospitalization Encounters Among US Adults, 2022-2023

Authors: Tenforde, Mark W;Fireman, Bruce;Zerbo, Ousseny;Klein, Nicola P;Klein, Nicola P;et al.

J Infect Dis. 2024 Jul 25;230(1):141-151.

PubMed abstract

Obstetric Complications and Birth Outcomes After Antenatal Coronavirus Disease 2019 (COVID-19) Vaccination

Authors: Vesco, Kimberly K;Zerbo, Ousseny;Vazquez-Benitez, Gabriela;et al.

Obstet Gynecol. 2024 Jun 01;143(6):794-802. Epub 2024-04-17.

PubMed abstract

Post-COVID conditions following COVID-19 vaccination: a retrospective matched cohort study of patients with SARS-CoV-2 infection

Authors: Malden, Debbie E;Zerbo, Ousseny;Tartof, Sara Y;et al.

Nat Commun. 2024 May 22;15(1):4101. Epub 2024-05-22.

PubMed abstract

Interim Effectiveness of Updated 2023-2024 (Monovalent XBB.1.5) COVID-19 Vaccines Against COVID-19-Associated Hospitalization Among Adults Aged ≥18 Years with Immunocompromising Conditions – VISION Network, September 2023-February 2024

Authors: Link-Gelles, Ruth;Klein, Nicola P;Zerbo, Ousseny;Fireman, Bruce;Payne, Amanda B;et al.

MMWR Morb Mortal Wkly Rep. 2024 Mar 28;73(12):271-276. Epub 2024-03-28.

PubMed abstract

Vaccine Effectiveness Against Pediatric Influenza-A-Associated Urgent Care, Emergency Department, and Hospital Encounters During the 2022-2023 Season, VISION Network

Authors: Adams, Katherine;Klein, Nicola P;Fireman, Bruce;Zerbo, Ousseny;Tenforde, Mark W;et al.

Clin Infect Dis. 2024 Mar 20;78(3):746-755.

PubMed abstract

Effectiveness of Recombinant Zoster Vaccine Against Herpes Zoster in a Real-World Setting

Authors: Zerbo, Ousseny;Bartlett, Joan;Fireman, Bruce;Lewis, Ned;Goddard, Kristin;Dooling, Kathleen;Duffy, Jonathan;Glanz, Jason;Naleway, Allison;Donahue, James G;Klein, Nicola P

Ann Intern Med. 2024 Feb;177(2):189-195. Epub 2024-01-09.

PubMed abstract

Impact of the COVID-19 Pandemic on Health Care Utilization in the Vaccine Safety Datalink: Retrospective Cohort Study

Authors: Qian, Lei;Zerbo, Ousseny;Xu, Stanley;et al.

JMIR Public Health Surveill. 2024 Jan 23;10:e48159. Epub 2024-01-23.

PubMed abstract

Influenza vaccine effectiveness against influenza-A-associated emergency department, urgent care, and hospitalization encounters among U.S. adults, 2022-2023

Authors: Tenforde, Mark W;Fireman, Bruce;Zerbo, Ousseny;Klein, Nicola P;Klein, Nicola P;et al.

J Infect Dis. 2023 Dec 02.

PubMed abstract

Effectiveness of COVID-19 vaccination during pregnancy by circulating viral variant

Authors: Zerbo, Ousseny;Ray, G Thomas;Fireman, Bruce;Layefsky, Evan;Goddard, Kristin;Ross, Pat;Greenberg, Mara;Klein, Nicola P

AJOG Glob Rep. 2023 Nov;3(4):100264. Epub 2023-08-25.

PubMed abstract

Challenges & opportunities for the epidemiological evaluation of the effects of COVID-19 vaccination on reproduction and pregnancy

Authors: Regan, Annette K;Fell, Deshayne B;Wise, Lauren A;Vazquez-Benitez, Gabriela;Håberg, Siri E;Ogar, Comfort;Yland, Jennifer J;Wesselink, Amelia K;Zerbo, Ousseny

Vaccine. 2023 Sep 22;41(41):5931-5935. Epub 2023-08-31.

PubMed abstract

Influenza Vaccination Among Pregnant People Before and During the Coronavirus Disease 2019 (COVID-19) Pandemic

Authors: Irving, Stephanie A;Kharbanda, Elyse;Klein, Nicola P;Naleway, Allison L;et al.

Obstet Gynecol. 2023 Sep 01;142(3):636-639. Epub 2023-08-03.

PubMed abstract

Clinical epidemiology and risk factors for critical outcomes among vaccinated and unvaccinated adults hospitalized with COVID-19-VISION Network, 10 States, June 2021-March 2023

Authors: Griggs, Eric P;McEvoy, Charlene;Konatham, Deepika;Hansen, John;Tenforde, Mark W;et al.

Clin Infect Dis. 2023 Aug 26.

PubMed abstract

Effectiveness of COVID-19 vaccines at preventing emergency department or urgent care encounters and hospitalizations among immunocompromised adults: An observational study of real-world data across 10 US states from August-December 2021

Authors: Embi, Peter J;Dunne, Margaret M;Stenehjem, Edward;Weber, Zachary A;Naleway, Allison L;et al.

Vaccine. 2023 Aug 23;41(37):5424-5434. Epub 2023-05-22.

PubMed abstract

Effectiveness of Monovalent and Bivalent mRNA Vaccines in Preventing COVID-19-Associated Emergency Department and Urgent Care Encounters Among Children Aged 6 Months-5 Years – VISION Network, United States, July 2022-June 2023

Authors: Link-Gelles, Ruth;Rowley, Elizabeth A K;Irving, Stephanie A;Weber, Zachary A;Fleming-Dutra, Katherine E;et al.

MMWR Morb Mortal Wkly Rep. 2023 Aug 18;72(33):886-892. Epub 2023-08-18.

PubMed abstract

Individual and neighborhood factors associated with being unvaccinated against COVID-19 among pregnant persons

Authors: Zerbo, Ousseny;Ray, G Thomas;Fireman, Bruce;Layefsky, Evan;Goddard, Kristin;Ross, Pat;Greenberg, Mara;Klein, Nicola P

Hum Vaccin Immunother. 2023 Aug 01;19(2):2256042.

PubMed abstract

Safety of simultaneous vaccination with COVID-19 vaccines in the Vaccine Safety Datalink

Authors: Kenigsberg, Tat'Yana A;Hanson, Kayla E;Klein, Nicola P;Weintraub, Eric S;et al.

Vaccine. 2023 Jul 19;41(32):4658-4665. Epub 2023-06-15.

PubMed abstract

Medically Attended Acute Adverse Events in Pregnant People After Coronavirus Disease 2019 (COVID-19) Booster Vaccination

Authors: DeSilva, Malini B;Williams, Joshua T B;Kharbanda, Elyse O;et al.

Obstet Gynecol. 2023 Jul 01;142(1):125-129. Epub 2023-05-09.

PubMed abstract

Relationships between social vulnerability and COVID-19 vaccination coverage and vaccine effectiveness

Authors: Dalton, Alexandra F;Zerbo, Ousseny;Tenforde, Mark W;et al.

Clin Infect Dis. 2023 May 03;76(9):1615-1625.

PubMed abstract

Effectiveness of BNT162b2 COVID-19 Vaccination in Children and Adolescents

Authors: Klein, Nicola P;Dalton, Alexandra F;Patel, Palak;Link-Gelles, Ruth;et al.

Pediatrics. 2023 May 01;151(5).

PubMed abstract

Protection of 2 and 3 mRNA Vaccine Doses Against Severe Outcomes Among Adults Hospitalized with COVID-19 – VISION Network, August 2021 – March 2022

Authors: DeSilva, Malini B; Klein, Nicola P; Zerbo, Ousseny; Fireman, Bruce; Gaglani, Manjusha; et al.

J Infect Dis. 2023 Apr 18;227(8):961-969.

PubMed abstract

Early Estimates of Bivalent mRNA Vaccine Effectiveness in Preventing COVID-19-Associated Emergency Department or Urgent Care Encounters and Hospitalizations Among Immunocompetent Adults – VISION Network, Nine States, September-November 2022

Authors: Tenforde, Mark W; Klein, Nicola P; Fireman, Bruce; Zerbo, Ousseny; Link-Gelles, Ruth; et al.

MMWR Morb Mortal Wkly Rep. 2023 Mar 17;71(53):1637-1646. Epub 2023-03-17.

PubMed abstract

Estimation of COVID-19 mRNA Vaccine Effectiveness and COVID-19 Illness and Severity by Vaccination Status During Omicron BA.4 and BA.5 Sublineage Periods

Authors: Link-Gelles, Ruth; Klein, Nicola P; Zerbo, Ousseny; Fireman, Bruce; Tenforde, Mark W; et al.

JAMA Netw Open. 2023 Mar 01;6(3):e232598. Epub 2023-03-01.

PubMed abstract

Maternal SARS-CoV-2 vaccination and infant protection against SARS-CoV-2 during the first six months of life

Authors: Zerbo, Ousseny; Ray, G Thomas; Fireman, Bruce; Layefsky, Evan; Goddard, Kristin; Lewis, Edwin; Ross, Pat; Omer, Saad; Greenberg, Mara; Klein, Nicola P

Nat Commun. 2023 Feb 28;14(1):894. Epub 2023-02-28.

PubMed abstract

Vaccine effectiveness against influenza-associated urgent care, emergency department, and hospital encounters during the 2021-2022 season, VISION Network

Authors: Tenforde, Mark W; Fireman, Bruce; Zerbo, Ousseny; Klein, Nicola P; et al.

J Infect Dis. 2023 Jan 23.

PubMed abstract

Early Estimates of Bivalent mRNA Vaccine Effectiveness in Preventing COVID-19-Associated Emergency Department or Urgent Care Encounters and Hospitalizations Among Immunocompetent Adults – VISION Network, Nine States, September-November 2022

Authors: Tenforde, Mark W; Klein, Nicola P; Fireman, Bruce; Zerbo, Ousseny; Link-Gelles, Ruth; et al.

MMWR Morb Mortal Wkly Rep. 2022 Dec 30;71(5152):1616-1624. Epub 2022-12-30.

PubMed abstract

Kawasaki Disease Following the 13-valent Pneumococcal Conjugate Vaccine and Rotavirus Vaccines

Authors: Kamidani, Satoshi; Zerbo, Ousseny; Weintraub, Eric S; et al.

Pediatrics. 2022 Dec 01;150(6).

PubMed abstract

Effectiveness of COVID-19 mRNA Vaccines Against COVID-19-Associated Hospitalizations Among Immunocompromised Adults During SARS-CoV-2 Omicron Predominance – VISION Network, 10 States, December 2021-August 2022

Authors: Britton, Amadea; Klein, Nicola P; Zerbo, Ousseny; Fireman, Bruce; Tenforde, Mark W; et al.

MMWR Morb Mortal Wkly Rep. 2022 Oct 21;71(42):1335-1342. Epub 2022-10-21.

PubMed abstract

Maternal SARS-CoV-2 Vaccination and Infant Protection Against SARS-CoV-2 During the First 6 Months of Life

Authors: Zerbo, Ousseny; Ray, G Thomas; Fireman, Bruce; Layefsky, Evan; Goddard, Kristin; Lewis, Edwin; Ross, Pat; Omer, Saad; Greenberg, Mara; Klein, Nicola

Res Sq. 2022 Oct 18.

PubMed abstract

Waning of vaccine effectiveness against moderate and severe covid-19 among adults in the US from the VISION network: test negative, case-control study

Authors: Ferdinands, Jill M; Klein, Nicola P; Zerbo, Ousseny; Fireman, Bruce; et al.

BMJ. 2022 10 03;379:e072141. Epub 2022-10-03.

PubMed abstract

Estimation of COVID-19 mRNA Vaccine Effectiveness Against Medically Attended COVID-19 in Pregnancy During Periods of Delta and Omicron Variant Predominance in the United States

Authors: Schrag, Stephanie J; Zerbo, Ousseny; Klein, Nicola P; Fireman, Bruce; Naleway, Allison L; et al.

JAMA Netw Open. 2022 09 01;5(9):e2233273. Epub 2022-09-01.

PubMed abstract

Risk of myocarditis and pericarditis following BNT162b2 and mRNA-1273 COVID-19 vaccination

Authors: Goddard, Kristin; Fireman, Bruce; Zerbo, Ousseny; Klein, Nicola P; et al.

Vaccine. 2022 Aug 19;40(35):5153-5159. Epub 2022-07-12.

PubMed abstract

Safety of COVID-19 Vaccination in US Children Ages 5-11 Years

Authors: Hause, Anne M; Klein, Nicola P; Fireman, Bruce; Zerbo, Ousseny; Shimabukuro, Tom T; et al.

Pediatrics. 2022 08 01;150(2).

PubMed abstract

Effectiveness of 2, 3, and 4 COVID-19 mRNA Vaccine Doses Among Immunocompetent Adults During Periods when SARS-CoV-2 Omicron BA.1 and BA.2/BA.2.12.1 Sublineages Predominated – VISION Network, 10 States, December 2021-June 2022

Authors: Link-Gelles, Ruth; Klein, Nicola P; Fireman, Bruce; Zerbo, Ousseny; Tenforde, Mark W; et al.

MMWR Morb Mortal Wkly Rep. 2022 Jul 22;71(29):931-939. Epub 2022-07-22.

PubMed abstract

Safety of Live-Attenuated Vaccines in Children Exposed to Biologic Response Modifiers in Utero

Authors: Zerbo, Ousseny; Klein, Nicola P; et al.

Pediatrics. 2022 07 01;150(1).

PubMed abstract

Lessons from a mature acellular pertussis vaccination program and strategies to overcome suboptimal vaccine effectiveness

Authors: Zerbo, Ousseny; Fireman, Bruce; Klein, Nicola P

Expert Rev Vaccines. 2022 07;21(7):899-907. Epub 2021-10-08.

PubMed abstract

Changes in incidence rates of outcomes of interest in vaccine safety studies during the COVID-19 pandemic

Authors: Xu, Stanley; Zerbo, Ousseny; Qian, Lei; et al.

Vaccine. 2022 05 20;40(23):3150-3158. Epub 2022-04-18.

PubMed abstract

Safety of measles and pertussis-containing vaccines in children with autism spectrum disorders

Authors: Zerbo, Ousseny; Fireman, Bruce; Klein, Nicola P; et al.

Vaccine. 2022 04 20;40(18):2568-2573. Epub 2022-03-18.

PubMed abstract

Effectiveness of Homologous and Heterologous COVID-19 Booster Doses Following 1 Ad.26.COV2.S (Janssen [Johnson & Johnson]) Vaccine Dose Against COVID-19-Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Adults – VISION Network, 10 States, December 2021-March 2022

Authors: Natarajan, Karthik; Klein, Nicola P; Fireman, Bruce; Zerbo, Ousseny; Dixon, Brian E; et al.

MMWR Morb Mortal Wkly Rep. 2022 Apr 01;71(13):495-502. Epub 2022-04-01.

PubMed abstract

Effectiveness of COVID-19 Pfizer-BioNTech BNT162b2 mRNA Vaccination in Preventing COVID-19-Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Nonimmunocompromised Children and Adolescents Aged 5-17 Years – VISION Network, 10 States, April 2021-January 2022

Authors: Klein, Nicola P; Fireman, Bruce; Zerbo, Ousseny; Verani, Jennifer R; et al.

MMWR Morb Mortal Wkly Rep. 2022 Mar 04;71(9):352-358. Epub 2022-03-04.

PubMed abstract

Waning 2-Dose and 3-Dose Effectiveness of mRNA Vaccines Against COVID-19-Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Adults During Periods of Delta and Omicron Variant Predominance – VISION Network, 10 States, August 2021-January 2022

Authors: Ferdinands, Jill M; Klein, Nicola P; Zerbo, Ousseny; Fireman, Bruce; et al.

MMWR Morb Mortal Wkly Rep. 2022 Feb 18;71(7):255-263. Epub 2022-02-18.

PubMed abstract

Effectiveness of a Third Dose of mRNA Vaccines Against COVID-19-Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Adults During Periods of Delta and Omicron Variant Predominance – VISION Network, 10 States, August 2021-January 2022

Authors: Thompson, Mark G; Klein, Nicola P; Fireman, Bruce; Zerbo, Ousseny; Ong, Toan C; et al.

MMWR Morb Mortal Wkly Rep. 2022 Jan 21;71(4):139-145. Epub 2022-01-21.

PubMed abstract

Population-based assessment of risks for severe COVID-19 disease outcomes

Authors: Zerbo, Ousseny; Lewis, Ned; Fireman, Bruce; Goddard, Kristin; Skarbinski, Jacek; Sejvar, James J; Azziz-Baumgartner, Eduardo; Klein, Nicola P

Influenza Other Respir Viruses. 2022 01;16(1):159-165. Epub 2021-08-25.

PubMed abstract

Associations of COVID-19-Related Health, Healthcare and Economic Factors With Prenatal Depression and Anxiety

Authors: Avalos, Lyndsay A; Nance, Nerissa; Badon, Sylvia E; Young-Wolff, Kelly; Ames, Jennifer; Zhu, Yeyi; Hedderson, Monique M; Ferrara, Assiamira; Zerbo, Ousseny; Greenberg, Mara; Croen, Lisa A

Int J Public Health. 2022;67:1604433. Epub 2022-05-04.

PubMed abstract

Contributions of COVID-19 Pandemic-Related Stressors to Racial and Ethnic Disparities in Mental Health During Pregnancy

Authors: Avalos, Lyndsay A; Nance, Nerissa; Zhu, Yeyi; Croen, Lisa A; Young-Wolff, Kelly C; Zerbo, Ousseny; Hedderson, Monique M; Ferrara, Assiamira; Ames, Jennifer L; Badon, Sylvia E

Front Psychiatry. 2022;13:837659. Epub 2022-03-14.

PubMed abstract

Effectiveness of two-dose vaccination with mRNA COVID-19 vaccines against COVID-19-associated hospitalizations among immunocompromised adults-Nine States, January-September 2021

Authors: Embi, Peter J; Klein, Nicola P; Fireman, Bruce; Zerbo, Ousseny; DeSilva, Malini B; et al.

Am J Transplant. 2022 01;22(1):306-314.

PubMed abstract

Laboratory-Confirmed COVID-19 Among Adults Hospitalized with COVID-19-Like Illness with Infection-Induced or mRNA Vaccine-Induced SARS-CoV-2 Immunity – Nine States, January-September 2021

Authors: Bozio, Catherine H; Klein, Nicola P; Fireman, Bruce; Zerbo, Ousseny; Stenehjem, Edward; et al.

MMWR Morb Mortal Wkly Rep. 2021 Nov 05;70(44):1539-1544. Epub 2021-11-05.

PubMed abstract

Effectiveness of 2-Dose Vaccination with mRNA COVID-19 Vaccines Against COVID-19-Associated Hospitalizations Among Immunocompromised Adults – Nine States, January-September 2021

Authors: Embi, Peter J; Klein, Nicola P; Fireman, Bruce; Zerbo, Ousseny; DeSilva, Malini B; et al.

MMWR Morb Mortal Wkly Rep. 2021 Nov 05;70(44):1553-1559. Epub 2021-11-05.

PubMed abstract

Surveillance for Adverse Events After COVID-19 mRNA Vaccination

Authors: Klein, Nicola P; Fireman, Bruce; Zerbo, Ousseny; Weintraub, Eric S; et al.

JAMA. 2021 10 12;326(14):1390-1399.

PubMed abstract

Effectiveness of Covid-19 Vaccines in Ambulatory and Inpatient Care Settings

Authors: Thompson, Mark G; Fireman, Bruce; Zerbo, Ousseny; Klein, Nicola P; et al.

N Engl J Med. 2021 10 07;385(15):1355-1371. Epub 2021-09-08.

PubMed abstract

COVID-19 Vaccination Coverage Among Insured Persons Aged ≥16 Years, by Race/Ethnicity and Other Selected Characteristics – Eight Integrated Health Care Organizations, United States, December 14, 2020-May 15, 2021

Authors: Pingali, Cassandra; Klein, Nicola P; Fireman, Bruce; Zerbo, Ousseny; Patel, Suchita A; et al.

MMWR Morb Mortal Wkly Rep. 2021 Jul 16;70(28):985-990. Epub 2021-07-16.

PubMed abstract

COVID-19 Vaccination Coverage Among Pregnant Women During Pregnancy – Eight Integrated Health Care Organizations, United States, December 14, 2020-May 8, 2021

Authors: Razzaghi, Hilda; Zerbo, Ousseny; Patel, Suchita A; et al.

MMWR Morb Mortal Wkly Rep. 2021 Jun 18;70(24):895-899. Epub 2021-06-18.

PubMed abstract

Genetic associations with a fever after measles-containing vaccines

Authors: Klein, Nicola P; Zerbo, Ousseny; Goddard, Kristin; Wang, Weiqi; Fohner, Alison E; Wiesner, Amy; Shokoohi, Vida; Coller, John; Bok, Karin; Gans, Hayley A

Hum Vaccin Immunother. 2021 06 03;17(6):1763-1769. Epub 2020-12-22.

PubMed abstract

Vaccine Safety Datalink infrastructure enhancements for evaluating the safety of maternal vaccination

Authors: Naleway, Allison L; Klein, Nicola P; Zerbo, Ousseny; Kharbanda, Elyse O; et al.

Ther Adv Drug Saf. 2021;12:20420986211021233. Epub 2021-06-14.

PubMed abstract

COVID-19 prevalence, symptoms, and sociodemographic disparities in infection among insured pregnant women in Northern California

Authors: Ames, Jennifer L; Ferrara, Assiamira; Avalos, Lyndsay A; Badon, Sylvia E; Greenberg, Mara B; Hedderson, Monique M; Kuzniewicz, Michael W; Young-Wolff, Kelly C; Zerbo, Ousseny; Zhu, Yeyi; Croen, Lisa A; et al.

PLoS One. 2021;16(9):e0256891. Epub 2021-09-03.

PubMed abstract

Identification and description of mumps cases in a non-outbreak setting and evaluation of the effectiveness of mumps-containing vaccines over time

Authors: Zerbo O; Modaressi S; Glanternik JR; Goddard K; Ross P; Lewis N; Klein NP

Hum Vaccin Immunother. 2020 12 01;16(12):3098-3102. Epub 2020-05-13.

PubMed abstract

Individual and Neighborhood Factors Associated with Failure to Vaccinate against Influenza during Pregnancy

Authors: Zerbo, Ousseny; Ray, G Thomas; Zhang, Lea; Goddard, Kristin; Fireman, Bruce; Adams, Alyce; Omer, Saad; Kulldorff, Martin; Klein, Nicola P

Am J Epidemiol. 2020 11 02;189(11):1379-1388.

PubMed abstract

Risk for Subdeltoid Bursitis After Influenza Vaccination: A Population-Based Cohort Study

Authors: Hesse EM; Navarro RA; Daley MF; Getahun D; Henninger ML; Jackson LA; Nordin J; Olson SC; Zerbo O; Zheng C; Duffy J

Ann Intern Med. 2020 08 18;173(4):253-261. Epub 2020-06-23.

PubMed abstract

Parental Risk Factors for Fever in their Children 7-10 Days After the First Dose of Measles-Containing Vaccines

Authors: Zerbo O; Modaressi S; Goddard K; Lewis E; Bok K; Gans H; Klein NP

Hum Vaccin Immunother. 2020 04 02;16(4):875-880. Epub 2019-11-08.

PubMed abstract

Order of Live and Inactivated Vaccines and Risk of Non-vaccine-targeted Infections in US Children 11-23 Months of Age

Authors: Newcomer SR; Zerbo O; Glanz JM; et al.

Pediatr Infect Dis J. 2020 03;39(3):247-253.

PubMed abstract

Trivalent inactivated influenza vaccine (IIV3) during pregnancy and six-month infant development

Authors: Avalos LA; Zerbo O; Li DK; et al.

Vaccine. 2020 02 28;38(10):2326-2332. Epub 2020-02-05.

PubMed abstract

Vaccine effectiveness of cell-culture relative to egg-based inactivated influenza vaccine during the 2017-18 influenza season

Authors: Klein NP; Fireman B; Goddard K; Zerbo O; Asher J; Zhou J; King J; Lewis N

PLoS One. 2020;15(2):e0229279. Epub 2020-02-26.

PubMed abstract

Infection and Fever in Pregnancy and Autism Spectrum Disorders: Findings from the Study to Explore Early Development

Authors: Croen LA; Zerbo O; Ames JL; et al.

Autism Res. 2019 10;12(10):1551-1561. Epub 2019-07-17.

PubMed abstract

An Exploratory Examination of Neonatal Cytokines and Chemokines as Predictors of Autism Risk: The Early Markers for Autism Study

Authors: Heuer LS; Croen LA; Jones KL; Yoshida CK; Hansen RL; Yolken R; Zerbo O; DeLorenze G; Kharrazi M; Ashwood P; Van de Water J

Biol Psychiatry. 2019 May 15.

PubMed abstract

Acellular Pertussis Vaccine Effectiveness Over Time

Authors: Zerbo O; Bartlett J; Goddard K; Fireman B; Lewis E; Klein NP

Pediatrics. 2019 07;144(1). Epub 2019-06-10.

PubMed abstract

Health Care Service Utilization and Cost Among Adults with Autism Spectrum Disorders in a U.S. Integrated Health Care System

Authors: Zerbo, Ousseny; Qian, Yinge; Ray, Thomas; Sidney, Steve; Rich, Steve; Massolo, Maria; Croen, Lisa A

Autism Adulthood. 2019 Mar 01;1(1):27-36. Epub 2019-03-11.

PubMed abstract

Factors Affecting Vaccination in Children and Their Siblings After Autism Spectrum Disorder Diagnosis-Reply

Authors: Zerbo O; Klein NP

JAMA Pediatr. 2018 10 01;172(10):985-986.

PubMed abstract

Vaccination Patterns in Children After Autism Spectrum Disorder Diagnosis and in Their Younger Siblings

Authors: Zerbo O; Fireman BH; Klein NP; et al.

JAMA Pediatr. 2018 05 01;172(5):469-475.

PubMed abstract

Association Between Estimated Cumulative Vaccine Antigen Exposure Through the First 23 Months of Life and Non-Vaccine-Targeted Infections From 24 Through 47 Months of Age

Authors: Glanz JM; Zerbo O; et al.

JAMA. 2018 03 06;319(9):906-913.

PubMed abstract

Use of acellular pertussis vaccines in the United States: can we do better?

Authors: Klein NP; Zerbo O

Expert Rev Vaccines. 2017 12;16(12):1175-1179. Epub 2017-10-20.

PubMed abstract

No association between influenza vaccination during pregnancy and adverse birth outcomes

Authors: Zerbo O; Modaressi S; Chan B; Goddard K; Lewis N; Bok K; Fireman B; Klein NP; Baxter R

Vaccine. 2017 May 31;35(24):3186-3190. Epub 2017-05-05.

PubMed abstract

Polychlorinated Biphenyl and Organochlorine Pesticide Concentrations in Maternal Mid-Pregnancy Serum Samples: Association with Autism Spectrum Disorder and Intellectual Disability

Authors: Lyall K; Croen LA; Sjödin A; Yoshida CK; Zerbo O; Kharrazi M; Windham GC

Environ Health Perspect. 2017 Mar;125(3):474-480. Epub 2016-08-23.

PubMed abstract

Autism with intellectual disability is associated with increased levels of maternal cytokines and chemokines during gestation

Authors: Jones KL; Croen LA; Yoshida CK; Heuer L; Hansen R; Zerbo O; DeLorenze GN; Kharrazi M; Yolken R; Ashwood P; Van de Water J

Mol Psychiatry. 2017 Feb;22(2):273-279. Epub 2016-05-24.

PubMed abstract

Association Between Influenza Infection and Vaccination During Pregnancy and Risk of Autism Spectrum Disorder

Authors: Zerbo O; Qian Y; Yoshida C; Fireman BH; Klein NP; Croen LA

JAMA Pediatr. 2017 Jan 02;171(1):e163609. Epub 2017-01-02.

PubMed abstract

Kaiser Permanente Northern California pregnancy database: Description and proof of concept study

Authors: Zerbo O; Chan B; Goddard K; Lewis N; Bok K; Klein NP; Baxter R

Vaccine. 2016 11 04;34(46):5519-5523. Epub 2016-10-07.

PubMed abstract

Maternal mid-pregnancy C-reactive protein and risk of autism spectrum disorders: the early markers for autism study

Authors: Zerbo O; Croen LA; et al.

Transl Psychiatry. 2016 Apr 19;6:e783. Epub 2016-04-19.

PubMed abstract

A Study of Physician Knowledge and Experience with Autism in Adults in a Large Integrated Healthcare System

Authors: Zerbo O; Massolo ML; Qian Y; Croen LA

J Autism Dev Disord. 2015 Dec;45(12):4002-14.

PubMed abstract

Maternal Infection During Pregnancy and Autism Spectrum Disorders

Authors: Zerbo O; Qian Y; Yoshida C; Grether JK; Van de Water J; Croen LA

J Autism Dev Disord. 2015 Dec;45(12):4015-25.

PubMed abstract

The health status of adults on the autism spectrum

Authors: Croen, Lisa A; Zerbo, Ousseny; Qian, Yinge; Massolo, Maria L; Rich, Steve; Sidney, Stephen; Kripke, Clarissa

Autism. 2015 Oct;19(7):814-23. Epub 2015-04-24.

PubMed abstract

Immune mediated conditions in autism spectrum disorders

Authors: Zerbo O; Leong A; Barcellos L; Bernal P; Fireman B; Croen LA

Brain Behav Immun. 2015 May;46:232-6. Epub 2015-02-11.

PubMed abstract

Neonatal cytokines and chemokines and risk of Autism Spectrum Disorder: the Early Markers for Autism (EMA) study: a case-control study

Authors: Zerbo O; Yoshida C; Grether JK; Van de Water J; Ashwood P; Delorenze GN; Hansen RL; Kharrazi M; Croen LA

J Neuroinflammation. 2014;11:113. Epub 2014-06-20.

PubMed abstract

A genome-wide survey of transgenerational genetic effects in autism

Authors: Tsang KM; Croen LA; Torres AR; Kharrazi M; Delorenze GN; Windham GC; Yoshida CK; Zerbo O; Weiss LA

PLoS ONE. 2013;8(10):e76978. Epub 2013-10-24.

PubMed abstract

Is maternal influenza or fever during pregnancy associated with autism or developmental delays? Results from the CHARGE (CHildhood Autism Risks from Genetics and Environment) study

Authors: Zerbo O; Iosif AM; Walker C; Ozonoff S; Hansen RL; Hertz-Picciotto I;

​J Autism Dev Disord. 2013 Jan;43(1):25-33. doi: 10.1007/s10803-012-1540-x.

PubMed abstract

​Month of conception and risk of autism

Authors: Zerbo O; Iosif AM; Delwiche L; Walker C; Hertz-Picciotto I;

​Epidemiology. 2011 Jul;22(4):469-75. doi: 10.1097/EDE.0b013e31821d0b53.

PubMed abstract

Related Stories

Mothers’ flu vaccination in pregnancy benefits babies in first months of life

Mothers’ flu vaccination in pregnancy benefits babies in first months of life

June 26, 2025

Pregnant patients are encouraged to get vaccinated against influenza because the illness can be more severe in pregnancy. New research from Kaiser Permanente shows prenatal inoculation also benefits infants during their first months of life.
Higher risk of COVID-19 hospitalization in babies too young for vaccine

Higher risk of COVID-19 hospitalization in babies too young for vaccine

October 24, 2024

An analysis of unvaccinated children who had COVID-19 found they were more likely to be hospitalized if they were 6 months old or younger, and more likely to be treated in an intensive care unit at ages 12 to 17.
Large study of shingles vaccine finds strong effectiveness over 4 years

Large study of shingles vaccine finds strong effectiveness over 4 years

January 8, 2024

The vaccine currently used to protect people against shingles maintains strong effectiveness over 4 years post-vaccination, according to a Kaiser Permanente-led research study.
COVID-19 vaccination of mother during pregnancy protects infant, though protection wanes

COVID-19 vaccination of mother during pregnancy protects infant, though protection wanes

February 28, 2023

Being vaccinated against COVID-19 during pregnancy provides protection for the baby through its first several months of life, a Kaiser Permanente analysis finds. Protection was stronger against the delta variant than the more recent omicron variant.

Our Team
Back To Top